FIELD: medicine.
SUBSTANCE: invention relates to field of ophthalmology. Ophthalmological medication in form of eye drops, contains 0.2-0.5 wt % of disulfiram, dissolved in pharmaceutically acceptable water-based carrier, 0.5-2.0 wt % of hydroxypropyl cyclodextrin, 2.0-5.0 wt % of taurine; agent, which ensures required resin condition, containing sodium chloride, sodium monohydrophosphate and dihydrophosphate, and methylparaben (nipagin) as a preservative.
EFFECT: invention ensures effective treatment of pathological conditions of eyes, such as cataract, glaucoma, ophthalmological hypertension and traumatic injuries of cornea, extends arsenal of existing preparations in form of eye drops.
6 cl, 5 tbl, 2 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINED OPHTHALMIC PREPARATION PRESENTED IN FORM OF EYE DROPS AND CONTAINING POLYHEXAMETHYLENE GUANIDINE AND TAURINE | 2012 |
|
RU2513997C1 |
| EYE DROPS BASED ON COMPOSITION OF PHARMACEUTICALLY ACCEPTABLE ADDITIVE ACID SALTS AND METHYLETHYL PYRIDONOL AND TAURINE CONTAINING COMPOSITION OF GROUP B VITAMINS | 2013 |
|
RU2533276C1 |
| COMBINED OPHTHALMIC AGENT | 2019 |
|
RU2733392C1 |
| EYE DROPS FOR TREATMENT OF DYSTROPHIC DISEASES AND TRAUMAS OF EYES | 2009 |
|
RU2414218C1 |
| EYE DROPS BASED ON PHARMACEUTICALLY TOLERABLE ADDITIVE SALTS OF ACID AND METHYL ETHYL ENCEPHABOL CONTAINING COMPOSITION OF VITAMINS B | 2013 |
|
RU2528912C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING EYE DISEASES RELATED TO EYE TISSUE METABOLIC DISEASE AND INFLAMMATORY EYE TISSUE INJURY | 2013 |
|
RU2521337C1 |
| OPHTHALMOLOGIC GEL OF TAURINE | 2016 |
|
RU2623205C1 |
| EYE DROPS | 2012 |
|
RU2504372C1 |
| INCLUSION COMPLEX OF DISULFIRAM AND CYCLODEXTRIN | 2015 |
|
RU2592625C1 |
| DOSAGE FORM BASED ON BUTYLAMINOHYDROXYPROPOXYPHENOXYMETHYL METHYLOXADIAZOLE | 2014 |
|
RU2585400C2 |
